Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

Publications

Hapani S, Chu D, Wu S

Eosinophilic pneumonia associated with bleomycin in a patient with mediastinal seminoma: a case report.

Journal of medical case reports 2010 Apr 29;4;126 — 2010 Apr 29 — 126

Santrach PJ, Askin FB, Wells RJ, Azizkhan RG, Merten DF

Nodular form of bleomycin-related pulmonary injury in patients with osteogenic sarcoma.

Cancer 1989 Aug 15;64;806-11 — 1989 Aug 15 — 806-11

Yousem SA, Lifson JD, Colby TV

Chemotherapy-induced eosinophilic pneumonia. Relation to bleomycin.

Chest 1985 Jul;88;103-6 — 1985 Jul — 103-6

Holoye PY, Luna MA, MacKay B, Bedrossian CW

Bleomycin hypersensitivity pneumonitis.

Annals of internal medicine 1978 Jan;88;47-9 — 1978 Jan — 47-9